According to the Enterprise Research App, recently, the Shanghai Defu Venture Capital Fund partnership was established, with an investment amount of about 217 million yuan. The business scope includes venture capital. Enterprise investigation and equity penetration showed that the partnership was jointly owned by Shanghai SDIC Leading Biomedical Private Equity Fund Partnership, Enhua Pharmaceutical, and Baili Tianheng Biomedical Technology Co., Ltd.

Zhitongcaijing · 2d ago
According to the Enterprise Research App, recently, the Shanghai Defu Venture Capital Fund partnership was established, with an investment amount of about 217 million yuan. The business scope includes venture capital. Enterprise investigation and equity penetration showed that the partnership was jointly owned by Shanghai SDIC Leading Biomedical Private Equity Fund Partnership, Enhua Pharmaceutical, and Baili Tianheng Biomedical Technology Co., Ltd.